Shawn, I. H., & Jamiruddin, M. R. (2024). Assessing therapeutic safety and efficacy of Pazopanib, Pembrolizumab plus Axitinib and Nivolumab plus Ipilimumab in Renal Cell Carcinoma: A systematic review and meta-analysis. Brac University.
Dyfyniad Arddull ChicagoShawn, Ibna Hasan, and Mohd. Raeed Jamiruddin. Assessing Therapeutic Safety and Efficacy of Pazopanib, Pembrolizumab Plus Axitinib and Nivolumab Plus Ipilimumab in Renal Cell Carcinoma: A Systematic Review and Meta-analysis. Brac University, 2024.
Dyfyniad MLAShawn, Ibna Hasan, and Mohd. Raeed Jamiruddin. Assessing Therapeutic Safety and Efficacy of Pazopanib, Pembrolizumab Plus Axitinib and Nivolumab Plus Ipilimumab in Renal Cell Carcinoma: A Systematic Review and Meta-analysis. Brac University, 2024.